Press Releases

Thermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument Solutions

Thermo Fisher Scientific has announced a series of co-marketing agreements, in addition to a new chromatography system and acquisition, to support scientists in driving their proteomics research forwards.

INFLAMMATIX AWARDED $1.7 MILLION GRANT FROM NATIONAL INSTITUTES OF HEALTH (NIH)

Inflammatix was awarded a $1.7 million grant from the National Institutes of Health (NIH) to support its development of a rapid diagnostic to identify immune subtypes (endotypes) of sepsis. Sepsis is a challenging disease with no available treatments, and the new test may enable endotype-specific therapies and/or the repurposing of available drugs to better treat sepsis.

Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research

The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform

BioPharma Dynamics unveil brand new cleanroom facility to support the Life Sciences Industry

BioPharma Dynamics has announced the opening of their new ISO Class 7 cleanroom facility located at new headquarters in Salford, Greater Manchester

UBIQUIGENT EXTENDS AND EXPANDS DRUG DISCOVERY COLLABORATION WITH BRISTOL MYERS SQUIBB

Ubiquigent has today announced the extension and expansion of its long-term collaboration with Bristol Myers Squibb.

Alfa Chemistry Newly Adds Drinking Water Disinfection Byproducts Standards for Water Safety Research

CD Formulation Offers Multiple Methods for Microbial Limit Test

LIQUID STABLE & READY-TO-USE TOTAL PROTEIN / ALBUMIN CLINICAL REFERENCE MATERIALS AVAILABLE FROM VERICHEM LABORATORIES

VERICHEM offers an extensive line of combined Total Protein/Albumin clinical reference materials specifically designed and manufactured for the calibration and calibration verification of Albumin and Total Protein assays on a wide number of clinical testing systems, including those from Abbott Diagnostics, Beckman Coulter, Roche Diagnostics, Siemens Healthineers.

New Instant Inoculator™ QC Microorganisms Eliminate Prep Work and Simplify Microbiology Control Testing with One-Step Method

Stratix Labs has unveiled Instant Inoculator™ QC microorganisms, a novel, ready-to-use product that delivers reference microorganisms to solid media with a simple one-step method.

Panthera@theRutherford clinical trial partnership has commenced the first UK multicentre oncology trial in prostate cancer with ten more oncology trials in the pipeline

The first multisite oncology trial undertaken by the independent sector in the UK has started treating its first patient at the Rutherford Cancer Centre North East.

CMOs will account for four of the five top bio manufacturing capacities in 2025

230 Covid-19 supply agreements known, with demand for larger biocapacity remaining constrained as a consequence of the circa 1000 vaccines in development

Emmes launches Orphan Reach™: Emmes’ Rare Disease Center

The new global Rare Disease center of Emmes expects accelerating growth from US and European biotechs

BIOFORTUNA DOUBLE THEIR MANUFACTURING CAPACITY

Biofortuna has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales.

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

Company plans wide ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client base

Christopher Flores, PhD Appointed as President and Chief Research and Development Officer of Doloromics, Inc.

Doloromics has announced the appointment of Dr. Chris Flores as their new President and Chief Research and Development Officer.

St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York

St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York. Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease.

BOC Sciences Provides a Metabolic Marker-Pseudouridine for Disease Diagnosis

Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX™ Testing at Primary Care Level

Renalytix Plc today announced the publication of results from an external chronic kidney disease budget impact analysis projecting 5-year savings of $1.1 billion for a population of 100,000 patients with type 2 diabetes (T2DKD) and chronic kidney disease tested with the Renalytix KidneyIntelX™ testing solution. Savings were driven by more effective pharmacy management and appropriate specialist referral compared to current standard of care for patients at high risk for disease progression and kidney failure.

Certara’s Simcyp™ COVID-19 Vaccine Model Named Finalist in Both the 2021 Citeline Awards and R&D 100 Awards

Certara’s Simcyp COVID-19 Vaccine Model uses biosimulation to improve decision-making and help optimize dosing regimens of COVID-19 vaccines. Certara calibrated its model using the structure of actual COVID-19 vaccines and validated it by replicating the published clinical data. The model, which is incorporated in Certara’s Vaccine Simulator™, addresses important questions such as differences in response with age and ethnicity, optimal timing between doses and expected duration of antibody response.